Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an Early Phase 1 study at H. Lee Moffitt Cancer Center examining whether exercise can boost responses to checkpoint blockad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING